Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Polyclonal Antibody

Anti-Human TDGF1/CRIPTO Polyclonal Antibody

Catalog #:   PHC97301 Specific References (45) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: ELISA, IHC, WB
Accession: P13385
Overview

Catalog No.

PHC97301

Species reactivity

Human

Host species

Rabbit

Isotype

IgG

Clonality

Polyclonal

Immunogen

E. coli - derived recombinant Human TDGF1/CRIPTO (Leu31-Thr172).

Tested applications

ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000

Target

Cripto-1 growth factor, Teratocarcinoma-derived growth factor 1, TDGF1, CRIPTO, Epidermal growth factor-like cripto protein CR1, CRGF

Purification

Purified by antigen affinity column.

Accession

P13385

Applications

ELISA, IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Data Image
  • Western Blot
    Recombinant Protein lysates were subjected to SDS PAGE followed by western blot with TDGF1/CRIPTO antibody (PHC97301) at 1 µg/ml.

    Lane 1: Recombinant Protein

    Second Ab: Goat Anti-Rabbit IgG H&L Polyclonal antibody, HRP (PTB96431) at 0.1 μg/mL.

    Predict MW: 17 kDa
    Observed MW: 17 kDa
References

Uncovering potential targets for antibody-drug conjugates in the treatment of gynecologic malignancies., PMID:40046734

Cripto-1 acts as a molecular bridge linking nodal to ALK4 via distinct structural domains., PMID:39840816

Recombinant humanized Fab fragments targeting the CFC domain of human Cripto-1., PMID:38150919

GWAS of Chronic Spontaneous Urticaria Reveals Genetic Overlap with Autoimmune Diseases, Not Atopic Diseases., PMID:35933036

A Novel Artificially Humanized Anti-Cripto-1 Antibody Suppressing Cancer Cell Growth., PMID:33567764

CRIPTO antagonist ALK4L75A-Fc inhibits breast cancer cell plasticity and adaptation to stress., PMID:33187540

An evaluation of different Cripto-1 antibodies and their variable results., PMID:31310365

Development of conformational antibodies targeting Cripto-1 with neutralizing effects in vitro., PMID:30703478

Targeting Nodal and Cripto-1: Perspectives Inside Dual Potential Theranostic Cancer Biomarkers., PMID:30207211

Administration of Cripto in GRP78 overexpressed human MSCs enhances stem cell viability and angiogenesis during human MSC transplantation therapy., PMID:29722092

Cripto-1 promotes epithelial-mesenchymal transition in prostate cancer via Wnt/β-catenin signaling., PMID:28098905

New Anti-Nodal Monoclonal Antibodies Targeting the Nodal Pre-Helix Loop Involved in Cripto-1 Binding., PMID:26370966

Cripto-1: an extracellular protein - connecting the sequestered biological dots., PMID:26327334

Cripto-1 as a novel therapeutic target for triple negative breast cancer., PMID:26059540

An antibody-cytotoxic conjugate, BIIB015, is a new targeted therapy for Cripto positive tumours., PMID:21458984

Targeting the embryonic gene Cripto-1 in cancer and beyond., PMID:21073352

Cripto-1: an embryonic gene that promotes tumorigenesis., PMID:20624125

Cripto-1 is a cell surface marker for a tumorigenic, undifferentiated subpopulation in human embryonal carcinoma cells., PMID:20549704

[Role of Cripto-1 protein in development and target therapy of breast cancer]., PMID:20388407

Human Cripto-1 as a target for a cancer vaccine: WO2008040759., PMID:19441915

Blockade of Cripto binding to cell surface GRP78 inhibits oncogenic Cripto signaling via MAPK/PI3K and Smad2/3 pathways., PMID:19421146

Cripto recruits Furin and PACE4 and controls Nodal trafficking during proteolytic maturation., PMID:18772886

Potential for cripto-1 in defining stem cell-like characteristics in human malignant melanoma., PMID:18604175

Regulation of Cripto-1 signaling and biological activity by caveolin-1 in mammary epithelial cells., PMID:18202186

Cripto-1 expression in uveal melanoma: an immunohistochemical study., PMID:17412323

Rabbit embryonic stem cell lines derived from fertilized, parthenogenetic or somatic cell nuclear transfer embryos., PMID:16996056

Cripto monoclonal antibodies., PMID:16193101

Cripto as a target for cancer immunotherapy., PMID:15934922

Role of human cripto-1 in tumor angiogenesis., PMID:15657343

Cripto: a novel target for antibody-based cancer immunotherapy., PMID:15173016

Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo., PMID:12925698

Decrypting the role of Cripto in tumorigenesis., PMID:12925690

A Nodal- and ALK4-independent signaling pathway activated by Cripto-1 through Glypican-1 and c-Src., PMID:12649175

Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein., PMID:11807813

Chick CFC controls Lefty1 expression in the embryonic midline and nodal expression in the lateral plate., PMID:11397007

Nuclear expression of the c-erbB-4/HER-4 growth factor receptor in invasive breast cancers., PMID:10749108

Synergistic growth inhibition and induction of apoptosis by a novel mixed backbone antisense oligonucleotide targeting CRIPTO in combination with C225 anti-EGFR monoclonal antibody and 8-Cl-cAMP in human GEO colon cancer cells., PMID:10425310

Cripto-1 indirectly stimulates the tyrosine phosphorylation of erb B-4 through a novel receptor., PMID:10085099

EGF-related peptides are involved in the proliferation and survival of MDA-MB-468 human breast carcinoma cells., PMID:9935161

Heregulin-dependent autocrine loop regulates growth of K-ras but not erbB-2 transformed rat thyroid epithelial cells., PMID:9648926

Cripto expression in human urological tumors., PMID:9022129

Transfection with a CRIPTO anti-sense plasmid suppresses endogenous CRIPTO expression and inhibits transformation in a human embryonal carcinoma cell line., PMID:8635871

Growth inhibition of human colon carcinoma cells by combinations of anti-epidermal growth factor-related growth factor antisense oligonucleotides., PMID:9816209

Identification and biological characterization of an epidermal growth factor-related protein: cripto-1., PMID:8006041

Expression of transforming growth factor alpha, amphiregulin and cripto-1 in human breast carcinomas., PMID:8180021

Datasheet
$ 170
Product specifications
50 μg 170 100 μg 280

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-Human TDGF1/CRIPTO Polyclonal Antibody [PHC97301]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only